The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amyloid Peptides Market Research Report 2025
Synopsis
Amyloid Peptides（Amyloid beta or Abeta) denotes peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients.The peptides derive from the amyloid precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ. Aβ molecules can aggregate to form flexible soluble oligomers which may exist in several forms.
The global Amyloid Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There has been a growing emphasis on biomarker research and the development of diagnostic tools for the early detection and monitoring of amyloid-related diseases, driving the demand for sensitive and specific assays capable of detecting and quantifying amyloid peptides in biological samples, facilitating early intervention and personalized treatment approaches.
This report aims to provide a comprehensive presentation of the global market for Amyloid Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyloid Peptides.
Report Scope
The Amyloid Peptides market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amyloid Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amyloid Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
rPeptide
AnaSpec, Inc
Genscript
BioLegend
NovoPro Inc.
Bio-Synthesis
AmideBio
Cambridge Research Biochemicals
Bachem
Segment by Type
Beta-Amyloid Mouse
Beta-Amyloid Rat
Beta-Amyloid Human
Segment by Application
Alzheimer's Disease Research
Cancer Research
Lewy Body Dementia Research
Inclusion Body Myositis Research
Cerebral Amyloid Angiopathy Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amyloid Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amyloid Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amyloid Peptides（Amyloid beta or Abeta) denotes peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients.The peptides derive from the amyloid precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ. Aβ molecules can aggregate to form flexible soluble oligomers which may exist in several forms.
The global Amyloid Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There has been a growing emphasis on biomarker research and the development of diagnostic tools for the early detection and monitoring of amyloid-related diseases, driving the demand for sensitive and specific assays capable of detecting and quantifying amyloid peptides in biological samples, facilitating early intervention and personalized treatment approaches.
This report aims to provide a comprehensive presentation of the global market for Amyloid Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyloid Peptides.
Report Scope
The Amyloid Peptides market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amyloid Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amyloid Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
rPeptide
AnaSpec, Inc
Genscript
BioLegend
NovoPro Inc.
Bio-Synthesis
AmideBio
Cambridge Research Biochemicals
Bachem
Segment by Type
Beta-Amyloid Mouse
Beta-Amyloid Rat
Beta-Amyloid Human
Segment by Application
Alzheimer's Disease Research
Cancer Research
Lewy Body Dementia Research
Inclusion Body Myositis Research
Cerebral Amyloid Angiopathy Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amyloid Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amyloid Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amyloid Peptides Market Overview
1.1 Product Overview and Scope of Amyloid Peptides
1.2 Amyloid Peptides Segment by Type
1.2.1 Global Amyloid Peptides Market Value Comparison by Type (2024-2030)
1.2.2 Beta-Amyloid Mouse
1.2.3 Beta-Amyloid Rat
1.2.4 Beta-Amyloid Human
1.3 Amyloid Peptides Segment by Application
1.3.1 Global Amyloid Peptides Market Value by Application: (2024-2030)
1.3.2 Alzheimer's Disease Research
1.3.3 Cancer Research
1.3.4 Lewy Body Dementia Research
1.3.5 Inclusion Body Myositis Research
1.3.6 Cerebral Amyloid Angiopathy Research
1.3.7 Others
1.4 Global Amyloid Peptides Market Size Estimates and Forecasts
1.4.1 Global Amyloid Peptides Revenue 2019-2030
1.4.2 Global Amyloid Peptides Sales 2019-2030
1.4.3 Global Amyloid Peptides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amyloid Peptides Market Competition by Manufacturers
2.1 Global Amyloid Peptides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amyloid Peptides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amyloid Peptides Average Price by Manufacturers (2019-2024)
2.4 Global Amyloid Peptides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amyloid Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amyloid Peptides, Product Type & Application
2.7 Amyloid Peptides Market Competitive Situation and Trends
2.7.1 Amyloid Peptides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amyloid Peptides Players Market Share by Revenue
2.7.3 Global Amyloid Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amyloid Peptides Retrospective Market Scenario by Region
3.1 Global Amyloid Peptides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amyloid Peptides Global Amyloid Peptides Sales by Region: 2019-2030
3.2.1 Global Amyloid Peptides Sales by Region: 2019-2024
3.2.2 Global Amyloid Peptides Sales by Region: 2025-2030
3.3 Global Amyloid Peptides Global Amyloid Peptides Revenue by Region: 2019-2030
3.3.1 Global Amyloid Peptides Revenue by Region: 2019-2024
3.3.2 Global Amyloid Peptides Revenue by Region: 2025-2030
3.4 North America Amyloid Peptides Market Facts & Figures by Country
3.4.1 North America Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amyloid Peptides Sales by Country (2019-2030)
3.4.3 North America Amyloid Peptides Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amyloid Peptides Market Facts & Figures by Country
3.5.1 Europe Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amyloid Peptides Sales by Country (2019-2030)
3.5.3 Europe Amyloid Peptides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amyloid Peptides Market Facts & Figures by Country
3.6.1 Asia Pacific Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amyloid Peptides Sales by Country (2019-2030)
3.6.3 Asia Pacific Amyloid Peptides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amyloid Peptides Market Facts & Figures by Country
3.7.1 Latin America Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amyloid Peptides Sales by Country (2019-2030)
3.7.3 Latin America Amyloid Peptides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amyloid Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amyloid Peptides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amyloid Peptides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amyloid Peptides Sales by Type (2019-2030)
4.1.1 Global Amyloid Peptides Sales by Type (2019-2024)
4.1.2 Global Amyloid Peptides Sales by Type (2025-2030)
4.1.3 Global Amyloid Peptides Sales Market Share by Type (2019-2030)
4.2 Global Amyloid Peptides Revenue by Type (2019-2030)
4.2.1 Global Amyloid Peptides Revenue by Type (2019-2024)
4.2.2 Global Amyloid Peptides Revenue by Type (2025-2030)
4.2.3 Global Amyloid Peptides Revenue Market Share by Type (2019-2030)
4.3 Global Amyloid Peptides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amyloid Peptides Sales by Application (2019-2030)
5.1.1 Global Amyloid Peptides Sales by Application (2019-2024)
5.1.2 Global Amyloid Peptides Sales by Application (2025-2030)
5.1.3 Global Amyloid Peptides Sales Market Share by Application (2019-2030)
5.2 Global Amyloid Peptides Revenue by Application (2019-2030)
5.2.1 Global Amyloid Peptides Revenue by Application (2019-2024)
5.2.2 Global Amyloid Peptides Revenue by Application (2025-2030)
5.2.3 Global Amyloid Peptides Revenue Market Share by Application (2019-2030)
5.3 Global Amyloid Peptides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 rPeptide
6.1.1 rPeptide Corporation Information
6.1.2 rPeptide Description and Business Overview
6.1.3 rPeptide Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 rPeptide Amyloid Peptides Product Portfolio
6.1.5 rPeptide Recent Developments/Updates
6.2 AnaSpec, Inc
6.2.1 AnaSpec, Inc Corporation Information
6.2.2 AnaSpec, Inc Description and Business Overview
6.2.3 AnaSpec, Inc Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AnaSpec, Inc Amyloid Peptides Product Portfolio
6.2.5 AnaSpec, Inc Recent Developments/Updates
6.3 Genscript
6.3.1 Genscript Corporation Information
6.3.2 Genscript Description and Business Overview
6.3.3 Genscript Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Genscript Amyloid Peptides Product Portfolio
6.3.5 Genscript Recent Developments/Updates
6.4 BioLegend
6.4.1 BioLegend Corporation Information
6.4.2 BioLegend Description and Business Overview
6.4.3 BioLegend Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioLegend Amyloid Peptides Product Portfolio
6.4.5 BioLegend Recent Developments/Updates
6.5 NovoPro Inc.
6.5.1 NovoPro Inc. Corporation Information
6.5.2 NovoPro Inc. Description and Business Overview
6.5.3 NovoPro Inc. Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NovoPro Inc. Amyloid Peptides Product Portfolio
6.5.5 NovoPro Inc. Recent Developments/Updates
6.6 Bio-Synthesis
6.6.1 Bio-Synthesis Corporation Information
6.6.2 Bio-Synthesis Description and Business Overview
6.6.3 Bio-Synthesis Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bio-Synthesis Amyloid Peptides Product Portfolio
6.6.5 Bio-Synthesis Recent Developments/Updates
6.7 AmideBio
6.6.1 AmideBio Corporation Information
6.6.2 AmideBio Description and Business Overview
6.6.3 AmideBio Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AmideBio Amyloid Peptides Product Portfolio
6.7.5 AmideBio Recent Developments/Updates
6.8 Cambridge Research Biochemicals
6.8.1 Cambridge Research Biochemicals Corporation Information
6.8.2 Cambridge Research Biochemicals Description and Business Overview
6.8.3 Cambridge Research Biochemicals Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cambridge Research Biochemicals Amyloid Peptides Product Portfolio
6.8.5 Cambridge Research Biochemicals Recent Developments/Updates
6.9 Bachem
6.9.1 Bachem Corporation Information
6.9.2 Bachem Description and Business Overview
6.9.3 Bachem Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bachem Amyloid Peptides Product Portfolio
6.9.5 Bachem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amyloid Peptides Industry Chain Analysis
7.2 Amyloid Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amyloid Peptides Production Mode & Process
7.4 Amyloid Peptides Sales and Marketing
7.4.1 Amyloid Peptides Sales Channels
7.4.2 Amyloid Peptides Distributors
7.5 Amyloid Peptides Customers
8 Amyloid Peptides Market Dynamics
8.1 Amyloid Peptides Industry Trends
8.2 Amyloid Peptides Market Drivers
8.3 Amyloid Peptides Market Challenges
8.4 Amyloid Peptides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
